# Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

> **NCT02538926** · PHASE2 · WITHDRAWN · sponsor: **University of Washington**

## Conditions studied

- B Acute Lymphoblastic Leukemia
- B Lymphoblastic Lymphoma
- Recurrent Adult Acute Lymphoblastic Leukemia
- Recurrent B Lymphoblastic Lymphoma
- Recurrent T Lymphoblastic Leukemia/Lymphoma
- Refractory B Lymphoblastic Lymphoma
- Refractory T Lymphoblastic Lymphoma
- T Acute Lymphoblastic Leukemia
- T Lymphoblastic Lymphoma

## Interventions

- **DRUG:** Asparaginase
- **DRUG:** Cyclophosphamide
- **DRUG:** Doxorubicin Hydrochloride
- **DRUG:** Etoposide
- **DRUG:** Imatinib Mesylate
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Prednisone
- **BIOLOGICAL:** Rituximab
- **DRUG:** Vincristine Sulfate

## Key facts

- **NCT ID:** NCT02538926
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-07-01
- **Primary completion:** 2020-07-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Drugs unavailable
- **Last updated:** 2018-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02538926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02538926, "Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02538926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*